-
Brefeldin A: From Trafficking to Assay Design
2026-08-31
Brefeldin A is a versatile trafficking perturbant for connecting ER–Golgi disruption with ER stress, cancer-cell phenotypes, and endothelial-barrier assay design. This article translates findings on moesin-dependent endothelial injury into a rigorous framework for interpreting BFA experiments without overstating cross-domain evidence.
-
VX-765 and the Logic of Separating Cell Death
2026-08-31
Translational inflammation research increasingly depends on distinguishing inflammatory pyroptosis from transcription-linked apoptosis. This article examines how VX-765 and its active metabolite VRT-043198 can help researchers isolate caspase-1 biology while using recent RNA Pol II findings to sharpen experimental interpretation.
-
(-)-Arctigenin: MEK1 Inhibitor Guide
2026-08-30
(-)-Arctigenin is a research-grade small molecule with reported nanomolar inhibition of MEK1 and LPS-induced iNOS expression. This guide separates product specifications, pathway evidence, breast-cancer-context interpretation, and practical assay limits.
-
MOF Nanoparticles for Non-Invasive Epilepsy Neuromodulation
2026-08-29
The reference study introduces ultrasound-activated, piezoelectric MOF-based nanoparticles designed to cross the blood–brain barrier and modulate epileptic neural activity without implanted electrodes. By combining brain-targeting ligands with platinum nanoclusters, the platform links receptor-mediated delivery, localized sononeuromodulation, and regulation of neuroinflammation and oxidative stress.
-
Exo1 for Mechanistic Exocytosis Assays
2026-08-28
Exo1, also known as methyl 2-(4-fluorobenzamido)benzoate, enables rapid dissection of Golgi–ER trafficking and ARF1-dependent secretion. This article explains how to use it as a mechanistic perturbation while avoiding the common mistake of treating broad secretory blockade as selective tumor extracellular vesicle inhibition.
-
Candida EVs, Nrg1, and Candidemia
2026-08-28
The reference study identifies a concentration-dependent self-inhibitory role for Candida albicans extracellular vesicles, linking EV exposure to SKO1-dependent induction of the hyphal repressor NRG1. Genetic and mouse infection experiments connect this transcriptional circuit with reduced hyphal development, improved survival, and lower fungal burden, while also defining important limits for therapeutic interpretation.
-
Proteinase K: From DNA Prep to Translational Insight
2026-08-27
Proteinase K is more than a routine digestion reagent. This thought-leadership guide explains how its broad-spectrum serine protease activity supports high-integrity DNA workflows, enables mechanistic studies of protein cargo, and can strengthen translational investigations inspired by recent Candida albicans extracellular-vesicle research.
-
Chondrocyte-Targeted NAC Nanoparticles in Osteoarthritis
2026-08-27
This 2025 Small Science study develops chondroitin sulfate-modified PLGA nanoparticles for sustained, chondrocyte-targeted delivery of N-acetylcysteine in osteoarthritis. The formulation preserves glutathione and GPX4 activity, suppresses ferroptosis under mechanical stress, and protects cartilage more effectively than free NAC or nontargeted nanoparticles in a murine model.
-
Dabigatran Etexilate: Translational Thrombin Strategy
2026-08-26
A mechanistic and translational guide to using Dabigatran etexilate as a direct thrombin inhibitor, from target engagement and coagulation assays to atrial fibrillation research and in vivo validation.
-
METTL16–SENP3–LTF Drives HCC Ferroptosis Resistance
2026-08-26
Wang et al. identify a METTL16–SENP3–LTF signaling axis that suppresses iron-dependent lipid peroxidation and promotes hepatocellular carcinoma progression. By combining epitranscriptomic, protein-turnover, genetic, organoid, animal, and clinical analyses, the study connects m6A-regulated RNA stability with iron sequestration and suggests a route for ferroptosis sensitization.
-
Stiripentol: Applied LDH Inhibitor Workflows
2026-08-25
Stiripentol offers a research-ready route to perturb LDH1/LDH5-dependent lactate flux in epilepsy, metabolic, and immune-cell assays. This guide turns its mechanism and solubility profile into practical workflows for astrocyte-neuron lactate shuttle studies, lactate measurements, and histone lactylation experiments.
-
CKI 7 dihydrochloride: Reliable CK1 Assays
2026-08-25
This scenario-driven guide explains how CKI 7 dihydrochloride, SKU B4936, can support controlled Casein kinase 1 inhibition studies in viability, proliferation, apoptosis, Wnt, circadian, and cancer biology workflows. It covers experimental controls, solution preparation, interpretation, and practical product-selection criteria without overstating evidence.
-
Reserpine (N1867): Practical Lab Workflow
2026-08-24
Reserpine (SKU N1867) provides a defined, high-purity research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers identity checks, DMSO preparation, storage, and assay controls; the material is for research use only and is not intended for diagnostic, clinical, or veterinary applications.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding
2026-08-24
The reference study shows that naturally occurring angiotensin peptides can enhance SARS-CoV-2 spike protein binding to host receptors, with effects determined by peptide length, receptor identity, and tyrosine modification. Its antibody-based binding experiments identify angiotensin (2–7) and related fragments as useful probes for investigating how renin-angiotensin signaling intersects with viral receptor engagement, while also highlighting important limits on biological interpretation.
-
Brefeldin A: From Trafficking Block to ER Stress
2026-08-23
Brefeldin A is more than a vesicle transport inhibitor: it is a temporal perturbation tool for connecting ER-to-Golgi traffic, protein quality control, and cancer-cell fate. This guide explains how to design and interpret BFA experiments using ER-stress adaptation as the central decision point.